Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery

Zavalloni, Dennis; Rossi, Marco; Scatturin, Melania; Morenghi, Emanuela; Soregaroli, Daniela; Municinò, Annamaria; Gasparini, Gabriele L.; Lisignoli, Veronica; Barbaro, Cristina; Presbitero, Patrizia

doi:10.1097/mca.0b013e3282cf4ba9

Cited by 11 publications

(5 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Knowledge available in the literature on the treatment of LAD stenosis located distally to its anastomosis with the LIMA or including the site of anastomosis is scarce and ambiguous. Attempts are being made to treat these lesions percutaneously or surgically, but none of these strategies has shown a clear advantage, and anatomical diversity implies the need to make individual decisions [2–4]. In the present case, the PCI procedure was fully successful as demonstrated angiographically and clinically.…”

Section: Discussionmentioning

confidence: 62%

Left anterior descending artery percutaneous coronary intervention via the left internal mammary artery in a 54-year-old type 1 diabetic woman: a

Kręcki¹,

Kasprzak²

2013

pwki

View full text Add to dashboard Cite

Data on the treatment of left anterior descending artery (LAD) stenosis involving or localized distally to left internal mammary artery anastomosis are scarce and not homogeneous. Both surgery (CABG) and percutaneous interventions (PCI) have been attempted, but the most effective treatment has not yet been established. We report a case of a 54-year-old woman suffering from chronic, stable angina and diabetes type 1 successfully treated with percutaneous angioplasty of LAD via the left internal mammary artery with drug-eluting stent implantation with excellent short-term results.

show abstract

Section: Discussionmentioning

confidence: 62%

Left anterior descending artery percutaneous coronary intervention via the left internal mammary artery in a 54-year-old type 1 diabetic woman: a

Kręcki¹,

Kasprzak²

2013

pwki

View full text Add to dashboard Cite

show abstract

“…Arterial graft dysfunction is usually caused by general atherosclerotic disease progression and neointimal hyperplasia caused by vascular trauma during CABG [ 90 ]. When comparing DES with BMS for percutaneous revascularization of internal mammary artery grafts, no statistically significant difference was found in the rates of TLR in several studies [ 91 , 92 ]. Patients with a history of CABG have a higher risk of cardiac death and TVR at 5-year follow-up, even if newer generation DES are used [ 93 ].…”

Section: In-stent Restenosismentioning

confidence: 99%

Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge

Donisan

Madanat

Balanescu

et al. 2023

CCR

View full text Add to dashboard Cite

In-stent restenosis (ISR) is a recognized complication following percutaneous coronary intervention in which the luminal diameter is narrowed through neointimal hyperplasia and vessel remodeling. Although rates of ISR have decreased in most recent years owing to newer generation drug-eluting stents, thinner struts, and better intravascular imaging modalities, ISR remains a prevalent dilemma that proves to be challenging to manage. Several factors have been proposed to contribute to ISR formation, including mechanical stent characteristics, technical factors during the coronary intervention, and biological aspects of drug-eluting stents. Presentation of ISR can range from asymptomatic to late myocardial infarction and could be difficult to differentiate from acute thrombus formation. No definite guidelines are present on the management of ISR. In this review, we will discuss the mechanisms underlying ISR and provide insight into patient-related and procedural risk factors contributing to ISR, in addition to highlighting common treatment approaches utilized in the management of ISR.

show abstract

“…Причиной этого является повреждение эндотелия вен в условиях артериальной гемодинамики, к которой вены не приспособлены. В результате происходит пролиферация гладкомышечных клеток (ГМК), ведущая к гиперплазии неоинтимы [17,19,20]. Другим механизмом облитерации венозных кондуитов является очаговая лейкоцитарная инфильтрация эндотелия вен, что также способствует потере их просвета [21].…”

Section: факторы риска и механизмы развитияunclassified

Acute coronary syndrome for patients with prior coronary artery bypass grafting: current state of the matter

Тарасов¹,

Bakovsky²

2018

Kardio. vestn.

View full text Add to dashboard Cite

ФГБНУ «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Россия В обзорной статье изложено современное представление о проблеме возникновения острого коронарного синдрома у пациентов, перенесших операцию коронарного шунтирования, факторах риска его развития, методах повторной реваскуляризации миокарда. Ключевые слова: острый коронарный синдром, коронарное шунтирование, повторное коронарное шунтирование, чрескожное коронарное вмешательство.

show abstract

Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery

Abstract: PCI of the stenoses of LIMA-to-LAD anastomoses with DES did not provide any clinical improvement over BMS use in long-term outcomes; DES use was associated with some cases of late thrombosis.

Cited by 11 publications

References 21 publications

Left anterior descending artery percutaneous coronary intervention via the left internal mammary artery in a 54-year-old type 1 diabetic woman: a

Left anterior descending artery percutaneous coronary intervention via the left internal mammary artery in a 54-year-old type 1 diabetic woman: a

Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge

Acute coronary syndrome for patients with prior coronary artery bypass grafting: current state of the matter

Contact Info

Product

Resources

About